Added a few more today at $7.32. GLTA
Does the recent acquisition have a significant impact on QIPT"s prospects?
The company acquired (Great Elm) makes sense for QIPT, being a respiratory company with presence in eight states and 270,000 customers. At $80M it is a sizeable deal, but adds $60M in revenue and $13M in EBITDA. There should be $2M in cost savings and it is accretive to cash flow. The market likes the deal. We think it is fine; we might have preferred the vendor take more in shares, to ensure alignment, but on the other hand, a mostly-cash deal is less dilutive. Good earnings growth is expected overall and we think the stock looks decent for a small cap heathcare name. (5iResearch)